Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with FOLFOX or FOLFIRI in RAS/B-RAF WT Metastatic Colorectal Cancer
NCT01858662Phase 2Terminated
- Start
- Jan 2014
- Primary completion
- Nov 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of KL-140 in colorectal cancer (metastatic) (mCRC). Started Jan 2014; status: terminated.
02
Drugs
KL-140
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01858662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01858662.